Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells

被引:70
作者
Dolfi, Douglas V. [1 ]
Boesteanu, Alina C. [1 ]
Petrovas, Constantinos [1 ]
Xia, Dong [2 ]
Butz, Eric A. [2 ]
Katsikis, Peter D. [1 ]
机构
[1] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA
[2] Amgen Inc, Inflammat Dept, Seattle, WA 98119 USA
关键词
D O I
10.4049/jimmunol.180.5.2912
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of costimulation has previously been confined to the very early stages of the CD8(+) T cell response. In this study, we demonstrate the requirement for CD27 costimulation during the later phase, but not programming of the primary CD8(+) T cell response to influenza virus and reveal a novel mechanism of action for CD27 costimulation. CD27 signals, during the later phase of the primary CD8(+) T cell response, prevent apoptosis of Ag-specific CD8(+) T cells. Blocking CD27L (CD70) on days 6 and 8 after infection reduces the number of NP(366-374)-specific CD8(+) T cells, increases their sensitivity to CD95/Fas-mediated apoptosis, and up-regulates FasL on CD4(+) T cells. This reduction of NP(366-374)-specific CD8(+) T cells requires the presence of CD4(+) T cells and Fas signaling. Lack of CD27 signals also decreases the quality of memory CD8(+) T cell responses. Memory CD8(+) T cells, which express surface CD27 similar to naive cells, however, do not require CD27 costimulation during a secondary response. Thus, CD27 acts indirectly to regulate primary Ag-specific CD8(+) T cell responses by preventing apoptosis of CD8(+) T cells during the later phase of the primary response and is required for optimal quality of memory cells, but is not required during normally primed secondary CD8(+) T cell responses.
引用
收藏
页码:2912 / 2921
页数:10
相关论文
共 51 条
[1]  
AGEMATSU K, 1995, J IMMUNOL, V154, P3627
[2]   Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis [J].
Akiba, H ;
Miyahira, Y ;
Atsuta, M ;
Takeda, K ;
Nohara, C ;
Futagawa, T ;
Matsuda, H ;
Aoki, T ;
Yagita, H ;
Okumura, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (02) :375-380
[3]   FAS TRANSDUCES ACTIVATION SIGNALS IN NORMAL HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
ARMITAGE, RJ ;
MARASKOVSKY, E ;
TOUGH, TW ;
ROUX, E ;
SCHOOLEY, K ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2231-2235
[4]   Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections [J].
Appay, V ;
Dunbar, PR ;
Callan, M ;
Klenerman, P ;
Gillespie, GMA ;
Papagno, L ;
Ogg, GS ;
King, A ;
Lechner, F ;
Spina, CA ;
Little, S ;
Havlir, DV ;
Richman, DD ;
Gruener, N ;
Pape, G ;
Waters, A ;
Easterbrook, P ;
Salio, M ;
Cerundolo, V ;
McMichael, AJ ;
Rowland-Jones, SL .
NATURE MEDICINE, 2002, 8 (04) :379-385
[5]   Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion [J].
Arens, R ;
Tesselaar, K ;
Baars, PA ;
van Schijndel, GMW ;
Hendriks, J ;
Pals, ST ;
Krimpenfort, P ;
Borst, J ;
van Oers, MHJ ;
van Lier, RAW .
IMMUNITY, 2001, 15 (05) :801-812
[6]   CD8+ T cell contraction is controlled by early inflammation [J].
Badovinac, VP ;
Porter, BB ;
Harty, JT .
NATURE IMMUNOLOGY, 2004, 5 (08) :809-817
[7]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[8]   Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo [J].
Blattman, JN ;
Grayson, JM ;
Wherry, EJ ;
Kaech, SM ;
Smith, KA ;
Ahmed, R .
NATURE MEDICINE, 2003, 9 (05) :540-547
[9]   CD27 mediates interieukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation [J].
Carr, James M. ;
Carrasco, Marlene J. ;
Thaventhiran, James E. D. ;
Bambrough, Paul J. ;
Kraman, Matthew ;
Edwards, Alexander D. ;
Al-Shamkhani, Aymen ;
Fearon, Douglas T. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (51) :19454-19459
[10]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A LIGAND FOR CD27 DEFINES A NEW FAMILY OF CYTOKINES WITH HOMOLOGY TO TUMOR-NECROSIS-FACTOR [J].
GOODWIN, RG ;
ALDERSON, MR ;
SMITH, CA ;
ARMITAGE, RJ ;
VANDENBOS, T ;
JERZY, R ;
TOUGH, TW ;
SCHOENBORN, MA ;
DAVISSMITH, T ;
HENNEN, K ;
FALK, B ;
COSMAN, D ;
BAKER, E ;
SUTHERLAND, GR ;
GRABSTEIN, KH ;
FARRAH, T ;
GIRI, JG ;
PATRICIABECKMANN, M .
CELL, 1993, 73 (03) :447-456